Structural Heart Disease: Year in Review
Structural heart disease therapies continue to evolve. Join us to hear about major recent advancements and studies for TAVR, mitral, tricuspid, LAAO, and novel device classes.
TAVR Year in Review
Chad Kliger, M.D., FSCAI, Northwell Health Lenox Hill Hospital, New York, NY